EI
BLFS icon

EAM Investors’s BioLife Solutions BLFS Stock Holding History

EAM Investors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,636
Closed -$1.9M – 346
2020
Q4 		$1.9M Sell
47,636
-6,038
-11% -$206K 0.31% 134
2020
Q3 		$1.55M Buy
+53,674
New +$1.16M 0.37% 99
2018
Q4 		– Sell
-78,535
Closed -$1.37M – 256
2018
Q3 		$1.37M Sell
78,535
-104,376
-57% -$2.06M 0.2% 174
2018
Q2 		$2.09M Buy
182,911
+88,180
+93% +$803K 0.33% 153
2018
Q1 		$484K Sell
94,731
-2,346
-2% -$12.7K 0.08% 275
2017
Q4 		$582K Hold
97,077
– – 0.1% 279
2017
Q3 		$555K Buy
+97,077
New +$403K 0.07% 274

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM Investors's BLFS Position: Q1 2021 in Review

EAM Investors sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 47,636 shares — an estimated $1.9M sold.

EAM Investors first reported a position in BLFS in Q3 2017 and held it in 7 quarters. The position peaked at $2.09M in Q2 2018. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

  • EAM Investors reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
  • EAM Investors sold 47,636 BioLife Solutions shares in Q1 2021, an estimated $1.9M.
  • EAM Investors first reported a position in BioLife Solutions in Q3 2017 and held it in 7 quarters.
  • EAM Investors's BioLife Solutions position peaked at $2.09M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.